Media Hub

View the latest content of the NASH Summit Boston and other events of the Fibrosis Series

NASH Summit FDA Presentation First Page

An exclusive FDA presentation by:


Dr Frank A. Anania, Acting Clinical Team Leader, Division of Gastroenterology and Inborn Error Products, FDA

NASH 2019 - Speaker Interview - Resar Cenar

NASH one pager

Speaker interview-resar cenar

Who attended in 2019 

Global Liver Institute, Donna Cryer

whos-attending-3rd NASH snippet
Global Liver Institute

Targeting multiple pathways in NASH - clinical perspectives for combination therapies | Nikolai Naoumov

Molecular MR Imaging of Oxidized Collagen to Monitor Active Fibrogenesis in Preclinical Models of NASH | Bryan Fuchs

Targeting multiple pathways
Molecular MR Imaging

Evaluating Progression Towards Industry Standard In Vitro Models of NAFLD/NASH

In Vitro